What You Should Know:
- 23andMe, a human genetics and biotechnology company, has announced its decision to initiate voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri.
- The bankruptcy filing is aimed at facilitating a structured sale
Read More
23andMe Files for Chapter 11 Bankruptcy to Facilitate Sale
